Home » Authors » Jim Stommen

Articles by Jim Stommen

Study: 'real value' outcomes, cost data involved in ICD use

May 7, 2008

Market/technology updates: Study cites positive outcomes, cost data involved in ICD use

May 1, 2008

The BB&T interview: Mike Mussallem CEO and INDUSTRY LEADER

May 1, 2008

New venture: Michigan hospital in launch of medical device resource

May 1, 2008

Acrobot takes aim at planning, navigating, assisting surgery

April 24, 2008

Commercialization competency is key resource at Beaumont

April 22, 2008

Acrobot takes aim at planning, navigating, assisting surgery

April 18, 2008

For Orthocrat, the vision is a filmless flow for surgeons

April 10, 2008

Hip resurfacing makes inroads but THR also sees tech gains

April 9, 2008

For Orthocrat, the vision is a filmless flow for surgeons

April 7, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 18, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...